Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Actos (pioglitazone hydrochloride) and Competact (pioglitazone hydrochloride and metformin hydrochloride) - Important Safety Information from Takeda as approved by the Irish Medicines Board

03 August 2011

Important Safety Information communication from Takeda on pioglitazone and a small increased risk of Urinary Bladder Cancer.

Important Safety Information - Actos and Competact





Date Printed: 22 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971